BioTech
Bayer Pharmaceuticals COO: The 2024 campaign is full of good intentions — and bad policy
As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being
Sebastian Guth
October 16, 2024